FDA Clearance Tracker · P070026-S021
CERAMAX CERAMIC TOTAL HIP SYSTEM
Last checked: Nov 20, 2026Latest source record: May 19, 2014 (this decision)Source: openFDAMethods & limitations
Decided
May 19, 2014
Approved
Time to decision
82 days
Received Feb 26, 2014. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P070026-S021
- Device name
- CERAMAX CERAMIC TOTAL HIP SYSTEM
- Applicant
- DePuy Orthopaedics, Inc.
- Applicant location
- Warsaw, IN
- Received
- Feb 26, 2014
- Decided
- May 19, 2014
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Postapproval Study Protocol - OSB
- Original approval
- P070026
Device type
- Device type
- Prosthesis, hip, semi-constrained, metal/ceramic/ceramic/metal, cemented or uncemented (MRA)
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
APPROVAL OF THE POST-APPROVAL STUDY PROTOCOL.
Source documents
Other decisions for DePuy Orthopaedics, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K262130 · Decided Sep 4, 2026 · 72 days after receipt
Device type: Prosthesis, Knee, Patellofemorotibial, Semi-Constrained, Cemented, Polymer/Metal/Polymer (JWH) · Orthopedic Surgery
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.